Sign in or register to see full information and data.

Studies / CAVD 294


Study information

Grant Affiliation:Letvin: rAdenoviral & rMycobacterial Vector Immunogens
Strategy:Vector vaccines (viral or bacterial)
Study Type:Pre-Clinical NHP
Species:Rhesus macaque
Stage:Assays Completed
Study Start Date:2009-10-20
Study Made Public:2012-04-10


Pilot study to assess immunogenicity of 1st generation recombinant Mycobacterial (rMyco) vaccine vectors


CAVD 294 is a non-human primate study comparing different doses and routes in BCG/Ad5 prime/boost regimens. A follow up boost study (CAVD 267) was performed.


rAd5-SIV rBCG Pasteur

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.